Hong Zhang Peking University First HospitalChina

Hong Zhang, MD & PhD.Dr. Hong Zhang is a Professor of Internal Medicine, Director of Renal division at Peking University First Hospital in China. She is the Board Committee Member of Chinese Society of Nephrology, the Nephrology in Chinese Medical Doctor Association, and the Vice-president of Nephrology Committee in Beijing Society of Medicine. She is also the member of ISN CME Advisory Committee, ISN-ACT Committee and ISN-CRP Committee.Dr. Hong Zhang received her MD from Peking University Medical School and PhD from Okayama University Medical School in Japan. She has been an Associate Research Scientist at Genetic Department, Yale University School of Medicine.Dr. Hong Zhang’s major research interesting focus on pathogenesis and clinical therapeutic strategies of glomerulonephritis. She has a renowned international reputation in clinical research in IgA nephropathy.

1 APRIL 2023

Time Session
14:15
15:15
Hans-Joachim Anders Chairperson hjanders@med.uni-muenchen.deLMU MUnichGermany
Hong Zhang Chairperson Peking University First HospitalChina
  • MCD/ FSGS: From Diagnosis to Treatment
    Michelle Rheault Speaker University of MinnesotaUnited States
  • MGN: From Pathomechanism to Novel Treatment Perspectives
    Nicola Tomas Speaker Germany
  • New Insights in Childhood Lupus Nephritis
    Prayong Vachvanichsanong Speaker Thailand
  • Q and A
Ballroom 1

30 MARCH 2023

Time Session
08:30
10:30
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Fundamentals of Clinical Trials
    David Wheeler Speaker University College LondonUnited Kingdom
  • Q and A
  • Core Statistics for Trials
    Natalie Staplin Speaker University of OxfordUnited Kingdom
  • Q and A
  • How Can Your Patient Co-design Your Trial?
    Nicki Scholes-Robertson Speaker Flinders UniversityAustralia
    William Herrington Speaker University of OxfordUnited Kingdom
  • Q and A
MR 110
11:00
13:00
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Establishing and Conducting Your Trial
    Hong Zhang Speaker Peking University First HospitalChina
  • Q and A
  • Global Representation in Large Trials
    Hernan Trimarchi Speaker HOSPITAL BRITANICO DE BUENOS AIRESArgentina
  • Q and A
  • Innovations in Trial Conduct
    Juliana Chan Speaker The Chinese University of Hong KongHong Kong, China
  • Q and A
MR 110
14:00
16:00
Dwomoa Adu Chairperson dwoms@blueyonder.co.ukGhana
Antonello Pani Chairperson antonello.pani@unica.itFull Professor and Director Renal UnitItaly
Sydney Tang Chairperson The University of Hong KongHong Kong, China
  • IgA Nephropathy: Epidemiology, Pathology, Clinical Features, Diagnosis, and Treatment of IgAN in China
    Hong Zhang Speaker Peking University First HospitalChina
  • New Antigens and Serology Based Approach in Membranous Nephropathy
    Pierre Ronco Speaker Hôpital TenonFrance
  • Kidney Size: Interaction with CKD Risk Factors in the Sardinian Population
    Antonello Pani Speaker antonello.pani@unica.itFull Professor and Director Renal UnitItaly
  • Q and A
MR 111
Meg Jardine Chairperson University of SydneyAustralia
Hiddo Lambers Heerspink Chairperson University medical Center GroningenNetherlands
Hong Zhang Chairperson Peking University First HospitalChina
  • Innovations in Trial Design
    Meg Jardine Speaker University of SydneyAustralia
  • Q and A
  • Bayesian Statistics in Trials
    Tom Snelling Speaker Professor in Infectious DiseasesAustralia
  • Q and A
  • Innovations in Trial Outcomes
    Hiddo Lambers Heerspink Speaker University medical Center GroningenNetherlands
  • Q and A
MR 110